Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04049097

Recruitment Status : Enrolling by invitation

First Posted : August 7, 2019

Last Update Posted : November 12, 2020

Sponsor:

Collaborators:

University of Kansas Medical Center

University College, London

Information provided by (Responsible Party):

Orphazyme

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Enrolling by invitation
Estimated Primary Completion Date :	May 22, 2022
Estimated Study Completion Date :	May 22, 2022

To Top